Shopify Pushes Canada Stocks Gauge to Record, Shy of 25,000
  • November 12, 2024

Shopify Pushes Canada Stocks Gauge to Record, Shy of 25,000

(Bloomberg) -- Canada’s stocks benchmark closed at a fresh record Tuesday thanks to gains in the country’s largest tech stock, but narrowly missed a key psychological threshold of 25,000 points.Most Read from BloombergUnder Trump, Prepare for New US Transportation PrioritiesThe Leaf Blowers Will Not Go QuietlyArizona Elections Signal Robust Immigration Enforcement Under TrumpScoring an Architectural Breakthrough in Denver’s RiNo DistrictThe S&P/TSX Composite Index gained as much as 1% to briefly

Wall Street Veteran Predicts S&P 500 To Hit 10,000 By 2029: 'Roaring 2020s'
  • November 12, 2024

Wall Street Veteran Predicts S&P 500 To Hit 10,000 By 2029: 'Roaring 2020s'

In a bold projection that's sure to grab attention, veteran Wall Street strategist Ed Yardeni is calling for the S&P 500 index to soar to 10,000 by the end of the decade due to a “Trump 2.0” boost after Donald Trump's recent election victory. Yardeni, a longtime market analyst, said Tuesday that Trump's return to the White House — alongside a likely Republican-controlled Congress — will bring in a major regime shift that's positive for U.S. stocks, the economy and corporate profits. Why Yardeni

Sea Stock Jumps As Shopping Demand Boosts Profit
  • November 12, 2024

Sea Stock Jumps As Shopping Demand Boosts Profit

(Bloomberg) -- Shares of Sea Ltd. jumped the most in more than a year-and-a-half after its e-commerce business reported its first profit on adjusted basis, a sign it’s holding its own against bigger Chinese rivals in Southeast Asian markets like Indonesia.Most Read from BloombergThe Leaf Blowers Will Not Go QuietlyArizona Elections Signal Robust Immigration Enforcement Under TrumpScoring an Architectural Breakthrough in Denver’s RiNo DistrictKey Ballot Initiatives and Local Races Highlight Views

Novavax Lowers 2024 Forecast Despite Q3 Revenue Beat, Stock Falls
  • November 12, 2024

Novavax Lowers 2024 Forecast Despite Q3 Revenue Beat, Stock Falls

On Tuesday, Novavax Inc (NASDAQ:NVAX) reported third-quarter 2024 sales of $84.5 million, compared to $186.99 million a year, beating the consensus of $65.78 million. Product sales of $38 million for the third quarter of 2024 were primarily related to U.S. market commercial sales. Licensing, royalties, and other revenue of $46 million in the third quarter of 2024 related to a combination of activities under the Sanofi Agreement and adjuvant sales. In September, the FDA granted Emergency Use Auth